Synapse - Wungki Park

Results (103)

BNT321, a novel monoclonal antibody targeting sialyl Lewis A: Phase 1 monotherapy and combination with mFOLFIRINOX in patients with advanced CA19-9 expressing cancers

Meeting Abstract

O'Reilly, E. M.; Bauer, T. M.; Borazanci, E. H.; Pelster, M.; Varghese, A. M.; Park, W.; Patel, M. R.; Jameson, G. S.; Larsen, M.; Chin, K.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Salvage hepatic artery infusion chemotherapy after first-line systemic failure in patients with unresectable cholangiocarcinoma

Meeting Abstract

Nasar, N.; Armstrong, M.; Chou, J. F.; Gonen, M.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; Kingham, T. P.; Wei, A. C. C.; D'Angelica, M. I.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Extrahepatic cholangiocarcinoma: Genomic variables associated with anatomical location and outcome

Meeting Abstract

Preston, W. A.; Drill, E. N.; Boerner, T.; Harding, J. J.; Cercek, A.; O'Reilly, E. M.; Abou-Alfa, G. K.; Park, W.; Balachandran, V. P.; Drebin, J. A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Intrahepatic cholangiocarcinoma: Recurrence patterns, genomics and survival

Meeting Abstract

Chandra, P.; Song, Y.; Drill, E. N.; Wei, A. C. C.; Kemeny, N. E.; Cercek, A.; Connell, L. C.; Harding, J. J.; Abou-Alfa, G. K.; Park, W.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Concordance in oncogenic alterations between the primary tumor and advanced disease: Insights into the heterogeneity of intrahepatic cholangiocarcinoma

Journal Article

McIntyre, S. M.; Preston, W. A.; Walch, H.; Sharib, J.; Kundra, R.; Sigel, C.; Lidsky, M. E.; Allen, P. J.; Morse, M. A.; Chen, W.; more...
JCO Precision Oncology (2024)

Fulltext@MSK | Save

Precision medicine for pancreatic cancer: Characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease

Journal Article

Keane, F.; Chou, J. F.; Walch, H.; Schoenfeld, J.; Singhal, A.; Cowzer, D.; Harrold, E.; O'Connor, C. A.; Park, W.; Varghese, A.; more...
JNCI: Journal of the National Cancer Institute (2024)

Fulltext@MSK | Save

Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer

Journal Article

McIntyre, C. A.; Grimont, A.; Park, J.; Meng, Y.; Sisso, W. J.; Seier, K.; Jang, G. H.; Walch, H.; Aveson, V. G.; Falvo, D. J.; more...
Cancer Cell (2024)

Fulltext@MSK | Save

Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors

Meeting Abstract

Park, W.; Zhang, J.; Dayyani, F.; Shan, J.; Liu, R.; Guo, R.; O'Reilly, E. M.; Liu, Z.; Gao, S.; Wu, X.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights

Meeting Abstract

Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes

Meeting Abstract

Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save